[{"bbox": [839, 100, 1316, 131], "category": "Page-header", "text": "特一药业集团股份有限公司 2023 年年度报告全文"}, {"bbox": [135, 175, 855, 214], "category": "Section-header", "text": "五、报告期内合并报表范围亏损超过上年末净资产10%"}, {"bbox": [135, 250, 290, 279], "category": "Text", "text": "□适用 ☑不适用"}, {"bbox": [135, 316, 699, 354], "category": "Section-header", "text": "六、报告期末除债券外的有息债务逾期情况"}, {"bbox": [135, 391, 290, 419], "category": "Text", "text": "□适用 ☑不适用"}, {"bbox": [135, 457, 669, 495], "category": "Section-header", "text": "七、报告期内是否有违反规章制度的情况"}, {"bbox": [135, 532, 225, 561], "category": "Text", "text": "□是 ☑否"}, {"bbox": [135, 598, 875, 636], "category": "Section-header", "text": "八、截至报告期末公司近两年的主要会计数据和财务指标"}, {"bbox": [1182, 672, 1295, 701], "category": "Text", "text": "单位：万元"}, {"bbox": [121, 703, 1305, 1181], "category": "Table", "text": "<table><thead><tr><th>项目</th><th>本报告期末</th><th>上年末</th><th>本报告期末比上年末增减</th></tr></thead><tbody><tr><td>流动比率</td><td>2.37</td><td>1.02</td><td>132.35%</td></tr><tr><td>资产负债率</td><td>19.98%</td><td>44.88%</td><td>-24.90%</td></tr><tr><td>速动比率</td><td>1.75</td><td>0.80</td><td>118.75%</td></tr><tr><td></td><td>本报告期</td><td>上年同期</td><td>本报告期比上年同期增减</td></tr><tr><td>扣除非经常性损益后净利润</td><td>24,901.21</td><td>17,338.96</td><td>43.61%</td></tr><tr><td>EBITDA 全部债务比</td><td>73.62%</td><td>25.58%</td><td>48.04%</td></tr><tr><td>利息保障倍数</td><td>39.29</td><td>14.10</td><td>178.65%</td></tr><tr><td>现金利息保障倍数</td><td>25.95</td><td>24.80</td><td>4.64%</td></tr><tr><td>EBITDA 利息保障倍数</td><td>48.30</td><td>19.50</td><td>147.69%</td></tr><tr><td>贷款偿还率</td><td>100.00%</td><td>100.00%</td><td>0.00%</td></tr><tr><td>利息偿付率</td><td>100.00%</td><td>100.00%</td><td>0.00%</td></tr></tbody></table>"}, {"bbox": [713, 1895, 739, 1920], "category": "Page-footer", "text": "84"}]